Dermatology’s growing focus on skin longevity demands clear definitions, validated outcomes, and rigorous evidence beyond anti-aging claims.
|Articles|February 1, 2004
Key categories
Washington - Dermatologists and their patients have numerous cosmeceutical products from which to choose. Those doctors who categorize the agents can better help their patients understand how the novel therapies fit into skincare regimens.
Advertisement
Advertisement
Related to this article
Castor oil has become a popular social media remedy for thicker, longer hair, but evidence supporting its ability to stimulate hair growth remains limited.
Can “Botox in a bottle” really rival injectable neuromodulators? We examine the evidence behind topical peptide serums and Argireline.
Advertisement
Advertisement
Trending on Dermatology Times
1
AAD, HS Foundation Issue First Joint Hidradenitis Suppurativa Guidelines
2
Dupilumab Associated With Lower Atopic March Risk in Pediatric Atopic Dermatitis
3
Lutikizumab Meets Primary End Point in Phase 3 HS Trial
4
Nonsteroidal Topicals Guide Special-Site Psoriasis Treatment Decisions
5